sciencebriefs
13:00in productionCh. 1 · A failed demonstration the year before/ 13:00 · ceiling 15 min
Medicine

History of general anesthesia

On 16 October 1846 William Morton administered ether so a surgeon could remove a tumour from a patient who felt no pain, a public proof of surgical anaesthesia that overshadowed an earlier, unpublished use of the same gas four years before.

At Massachusetts General Hospital on 16 October 1846, the dentist William Morton administered inhaled ether to a young printer named Edward Gilbert Abbott, allowing surgeon John Collins Warren to remove a neck tumour without Abbott reporting any pain, a demonstration that ended with Warren's remark that this was no humbug. News of the success spread to Europe and across America within weeks, quickly overshadowing an earlier failed attempt, a nitrous oxide demonstration by Horace Wells the previous year that had gone wrong when the patient cried out. Morton's claim to priority was disputed almost immediately, both by Charles Jackson, who said Morton had taken the idea from him, and by the fact that Crawford Long had used ether for a similar operation back in 1842 without publishing the result until years later, leaving Morton's public demonstration, rather than any single discovery, as the moment credited with launching modern surgical anaesthesia.

Chapters & takeaways6
  1. 0:08
    A failed demonstration the year before

    In January 1845, Horace Wells's public attempt to demonstrate nitrous oxide anaesthesia at the same hospital failed when the patient cried out in pain.

  2. 2:10
    A private success, then a public one

    After testing ether privately on a patient in September 1846, Morton arranged a public demonstration for 16 October.

  3. 4:20
    No pain, and no humbug

    Surgeon John Collins Warren removed a tumour from Edward Gilbert Abbott's neck while Abbott, under ether, felt no pain, prompting Warren's remark that the result was no humbug.

  4. 6:30
    A discovery already made, and unpublished

    Crawford Long had used ether for a comparable operation back in 1842 but did not publish the result until years later, forfeiting the priority Morton's public demonstration claimed instead.

  5. 8:40
    A dispute that outlasted the demonstration

    Charles Jackson claimed Morton had taken the idea of ether anaesthesia from him, beginning a dispute over credit that continued for years.

  6. 10:50
    Why the public moment mattered more than the private one

    Worth understanding because it shows how being demonstrated openly, not merely being first, is often what actually changes medical practice.

Worth your time?

Yes. Study the whole thing.

4.5/ 5
What works
  • the vivid contrast between Wells's failed 1845 demonstration and Morton's successful one the following year, in the very same room
  • the honest complication that Crawford Long had already done something similar in 1842 without publishing it
  • the closing detail of Warren's own words at the moment the demonstration succeeded
What does not
  • it does not settle the priority dispute between Morton and Jackson beyond describing that it happened
  • it does not explain why ether specifically, among the gases already known to alter consciousness, became the one adopted
Study it if
  • readers who assume the first use of something is always the one that gets remembered
  • anyone curious about the failed 1845 attempt that came right before the successful one
  • readers interested in priority disputes in the history of medicine
Skip it if
  • readers wanting the pharmacology of how ether or its successors act on the nervous system
  • anyone after a single settled answer to who really discovered anaesthesia
The written brief3 min read

A failed demonstration the year before

On 20 January 1845, a dentist named Horace Wells attempted to demonstrate nitrous oxide as a surgical anaesthetic in the same Massachusetts General Hospital operating theatre that would later host the successful ether demonstration. The attempt failed: the patient cried out during the procedure, and the assembled audience of physicians and medical students left unconvinced that the gas had actually blocked any pain at all. That public failure meant any later demonstration of surgical anaesthesia would have to overcome real, freshly reinforced scepticism, since the most recent public attempt at exactly this claim had visibly and memorably not worked.

A private success, then a public one

William Morton, another dentist, had been experimenting with ether, a substance already known socially through recreational ether frolics he had attended years earlier, and tested it privately on a patient named Eben Frost on 30 September 1846 with promising results. Building on that private success, Morton arranged a public demonstration at the same hospital theatre for 16 October 1846, working with surgeon John Collins Warren, the first dean of Harvard Medical School, who agreed to operate on a patient while Morton administered the gas using an apparatus he had built for the purpose.

No pain, and no humbug

During the operation, Morton held the delivery apparatus to the mouth of the patient, a young printer named Edward Gilbert Abbott, and had him breathe until he lost consciousness within three to four minutes. Warren then removed part of a tumour from the left side of Abbott’s neck; Abbott later reported feeling only a scratching sensation rather than pain, and Warren addressed the assembled physicians afterward with the remark that this was no humbug, a direct reference to the credibility problem left by Wells’s failed attempt the year before. News of the successful demonstration spread to Europe and across America within weeks, carried in part by an account published almost immediately by Henry Jacob Bigelow.

A discovery already made, and unpublished

Morton’s claim to have introduced surgical anaesthesia was contested almost immediately and on more than one front. Charles Jackson, a chemist who had discussed ether’s properties with Morton beforehand, argued that Morton had taken the underlying idea from him rather than developing it independently, beginning a dispute over credit that continued for years afterward. Separately, and more decisively for the historical record, Crawford Long had already administered ether to remove a tumour from a patient’s neck back on 30 March 1842, four years before Morton’s demonstration, but he did not publish an account of the operation until 1849, well after Morton’s public success had already been widely reported and credited.

A dispute that outlasted the demonstration

What actually followed from Morton’s demonstration was rapid and consequential regardless of the priority dispute: Robert Liston performed the first amputation under ether within two months, in December 1846, and within a year the Scottish obstetrician James Young Simpson had introduced chloroform as an alternative anaesthetic. Ether’s use spread widely enough that by 1853 the physician John Snow was administering an anaesthetic, chloroform, to Queen Victoria during childbirth, a moment credited with helping legitimise anaesthesia specifically in obstetric practice. Ether itself remained a standard surgical anaesthetic for many decades before safer alternatives, including halothane from 1956 and later isoflurane, sevoflurane and desflurane, gradually replaced it.

Why the public moment mattered more than the private one

This is worth understanding because it separates two things that get blurred together in popular retellings: who first did something, and whose demonstration of it actually changed practice. Crawford Long administered ether for surgery years before Morton did, yet it is Morton’s public, witnessed, and immediately publicised demonstration at Massachusetts General Hospital that is credited with launching the era of surgical anaesthesia, precisely because an unpublished private success could not do the work of persuading the wider medical community the way a documented public one could. An hour spent on the full sequence, the failed 1845 attempt, Morton’s private test, the public demonstration, and the priority dispute that followed, gives a clearer sense of how medical practice actually changes than the single-inventor version usually told.

Same field · Medicine4 of 84
13:00
Combined oral contraceptive pill1961Backed by funding that Margaret Sanger and Katharine McCormick secured for his laboratory, Gregory Pincus worked with Min Chueh Chang to confirm that progesterone could suppress ovulation, then partnered with physician John Rock to test the approach first on infertility patients in Massachusetts and then, at larger scale, on women at birth control clinics in Puerto Rico from 1955. Despite a trial supervisor's report that the drug, sold as Enovid, caused side effects serious enough to be unacceptable, Pincus and Rock pressed ahead, and the Food and Drug Administration approved it for contraceptive use in May 1960. The pill went on to be used by well over 100 million women worldwide, cited widely as a catalyst for broader social change, even as its cardiovascular and cancer risks, weighed against its near-complete effectiveness at preventing pregnancy, remain part of how it is prescribed today.
13:00
Magnetic resonance imagingMagnetic resonance imaging builds on nuclear magnetic resonance, the fact that certain atomic nuclei absorb and re-emit radio energy when placed in a magnetic field. Paul Lauterbur's 1973 paper showed that adding gradients across that magnetic field let the origin of the emitted signal be located in space, turning a single spectroscopic reading into a two-dimensional image; Peter Mansfield then developed the Fourier transform methods needed to make image reconstruction fast enough to be practical. The 2003 Nobel Prize in Physiology or Medicine went to Lauterbur and Mansfield alone, a decision Raymond Damadian publicly disputed on the grounds of his own earlier work identifying magnetic differences between cancerous and healthy tissue.
13:00
History of penicillinFrom 1939, Howard Florey assembled a team at Oxford, including Ernst Chain and Norman Heatley, that purified enough penicillin to cure infected mice in May 1940 and, in February 1941, to treat a human patient, Albert Alexander, whose initial recovery ended in death only because supplies ran out. Florey and Heatley then travelled to the United States in 1941 to find manufacturers, where a Peoria laboratory's deep-tank fermentation method and a higher-yielding mould strain found on a market cantaloupe let American production scale from a research curiosity to billions of units a year by 1944. Chain wanted to patent the production process to protect British interests, but Florey and British colleagues considered profiting from the discovery unethical, so American firms patented their methods instead, later forcing British manufacturers to pay them royalties, a decision whose costs became clear only once the antibiotic era Florey's team had done so much to launch was already under way.
13:00
CiclosporinIn 1971 Sandoz researchers in Basel isolated a new fungal strain that a colleague had brought back from Norway, and the following year Jean-Francois Borel identified that one of its natural products, later named cyclosporine, suppressed the immune system by blocking the activation of a type of white blood cell called a T-cell, a property discovered through a screening test rather than through the antifungal activity the compound had originally been isolated for. British surgeon Roy Calne demonstrated its usefulness in kidney transplants from 1978, Thomas Starzl performed the first successful liver transplant using it in 1980, and the drug received FDA approval in 1983, substantially improving survival after organ transplantation by controlling rejection more effectively than earlier immunosuppressants. Cyclosporine came with its own costs, including raised blood pressure, kidney damage and an increased risk of certain cancers, and credit for the discovery itself was later disputed between Borel and Sandoz colleague Hartmann Stahelin.
Up next in Science

Ancient DNA

· 13:00

Svante Pääbo spent decades building the methods to pull authentic genetic sequences out of fossils riddled with damage and contamination, work that let him sequence the Neanderthal genome and identify a new human relative from a single finger bone.

13:00